Product
ANB-010
Aliases
ANB-010, dose 1, ANB-010, dose 2, ANB-010, dose 3
1 clinical trial
1 indication
Indication
Hemophilia AClinical trial
An Open-Label Two-Stage Trial of the Safety, Pharmacodynamics, Biodistribution, Immunogenicity and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia AStatus: Recruiting, Estimated PCD: 2025-12-01